Skip to main content
. 2021 May 20;12:671867. doi: 10.3389/fneur.2021.671867

Table 2.

Subgroup analysis between LGGs, mixed-grade gliomas, and HGGs; between static PET scan and dynamic PET scan; and between visual assessment of the PET scan and semi-quantitative parametric analysis.

Radiotracer and parameter Subgroup Number of studies/PET scan tests Pooled Sen and its 95%CI P-value Pooled Spe and its 95%CI P-value Pooled DOR and its 95%CI AUC PINTERACTION*
18F-FET, TBRmax HGGs 6/333 0.92 (0.85,0.98) 0.51 0.88 (0.79,0.96) 0.90 75 (18,304) 0.92 0.04
Gliomas of mixed grades 8/477 0.84 (0.75,0.93) 0.71 (0.61,0.81) 12 (6,23) 0.80
Static scan 5/311 0.94 (0.88,0.99) 0.80 0.76 (0.62,0.90) 0.09 47 (7,299) 0.92 0.10
Dynamic scan 9/810 0.82 (0.73,0.91) 0.79 (0.71,0.88) 15 (7,32) 0.86
PET performed ≤7d after SRR 3/108 0.84 (0.76,0.92) 0.19 0.79 (0.56,1.00) 0.64 NA NA 0.34
PET performed >7d after SRR 4/233 0.76 (0.68,0.84) 0.82 (0.68,0.95) NA NA
18F-FDG Visual assessment 8/355 0.76 (0.63,0.85) 0.30 0.90 (0.81,0.95) <0.05 29 (14,60) 0.92 0.17
Semi-quantitative parametric analysis 7/349 0.83 (0.73,0.90) 0.82 (0.72,0.89) 23 (10,51) 0.85
HGGs 11/214 0.76 (0.68,0.83) 0.82 (0.70,0.90) 15 (7,33) 0.84
Gliomas of mixed grades 7/417 0.76 (0.58,0.88) 0.31 0.87 (0.80,0.92) <0.05 21 (8,52) 0.88 0.64
LGGs 5/141 0.61 (0.34,0.83) 0.83 0.90 (0.77,0.96) 0.02 15 (3,88) 0.90 0.10
11C-MET, TBR HGGs 3/248 0.94 (0.87,1.00) 0.95 0.82 (0.69,0.95) 0.47 71 (20,251) 0.95 0.58
Gliomas of mixed grades 4/384 0.89 (0.78,0.99) 0.77 (0.67,0.86) 29 (7, 117) 0.79
PET performed <20 m after RT 2/92 0.96 (0.91,1.00) 0.89 0.71 (0.53,0.89) 0.04 NA NA 0.11
PET performed >20 m after RT 4/110 091 (0.84,0.97) 0.89 (0.79,0.99) NA NA
18F-DOPA Visual assessment 3/175 0.86 (0.80,0.92) <0.05 0.72 (0.59,0.86) 0.22 16 (4,62) 0.93 0.8
Semi-quantitative analysis of TBRmax 3/175 0.84 (0.77,0.90) 0.68 (0.54,0.83) 14 (4,50) 0.85

AUC, area under receiver operating curve; CI, confidence interval; DOR, diagnostic odds ratio; HGGs, high-grade gliomas; LGGs, low-grade gliomas; SRR, suspicious recurrence of glioma; TBR, tumor-to-brain ratio. Bold face type indicates statistical significance. *Based on meta regression.

Compared with group of HGGs.